Inventor · disambiguated record
Henry Jackson
Also filed as: JACKSON HENRY · JACKSON HENRY L · Jackson Henry Lee
15 granted patents·11 pending applications·80 citations·filing 2003–2020
90Inventor score
Top patents by PatentIndex Score
26 records- 0190US7145025B2Structural carotenoid analogs for the inhibition and amelioration of diseaseHAWAII BIOTECH INC·Filed 2003·Granted Dec 5, 2006·39 cites·8 claims
- 0289US7247752B2Methods for the synthesis of astaxanthinCARDAX PHARMACEUTICALS INC·Filed 2005·Granted Jul 24, 2007·13 cites·34 claims
- 0375US7592449B2Structural carotenoid analogs for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2006·Granted Sep 22, 2009·2 cites·29 claims
- 0473US7691901B2Carotenoid analogs or derivatives for the inhibition and amelioration of inflammationCARDAX PHARMACEUTICALS INC·Filed 2005·Granted Apr 6, 2010·2 cites·34 claims
- 0573US7521584B2Carotenoid analogs or derivatives for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Apr 21, 2009·7 cites·21 claims
- 0673US7317008B2Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injuryCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Jan 8, 2008·6 cites·52 claims
- 0770US7723327B2Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted May 25, 2010·5 cites·60 claims
- 0861US7763649B2Carotenoid analogs or derivatives for controlling connexin 43 expressionCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Jul 27, 2010·2 cites·45 claims
- 0960US12338209B2Astaxanthin esters and methods of use thereofCARDAX INC·Filed 2020·Granted Jun 24, 2025·0 cites·19 claims
- 1058US7345091B2Carotenoid ether analogs or derivatives for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Mar 18, 2008·2 cites·16 claims
- 1157US7375133B2Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted May 20, 2008·1 cites·35 claims
- 1256US7320997B2Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·1 cites·74 claims
- 1350US9688618B2Hydroxamic acids and uses thereofHAWAII BIOTECH INC·Filed 2016·Granted Jun 27, 2017·0 cites·16 claims
- 1449US9505710B2Hydroxamic acids and uses thereofHAWAII BIOTECH INC·Filed 2016·Granted Nov 29, 2016·0 cites·24 claims
- 1547US2005004235A1Carotenoid analogs or derivatives for the inhibition and amelioration of liver diseaseFiled 2004·Application pending·0 cites
- 1647US2005059635A1Carotenoid ester analogs or derivatives for controlling C-reactive protein levelsFiled 2004·Application pending·0 cites
- 1747US2005026874A1Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver diseaseFiled 2004·Application pending·0 cites
- 1842US7435861B2Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediatesCARDAX PHARMACEUTICALS INC·Filed 2006·Granted Oct 14, 2008·0 cites·14 claims
- 1941US2005148517A1Carotenoid ether analogs or derivatives for controlling connexin 43 expressionFiled 2004·Application pending·0 cites
- 2041US2005059659A1Carotenoid analogs or derivatives for controlling C-reactive protein levelsFiled 2004·Application pending·0 cites
- 2141US2005143475A1Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injuryFiled 2004·Application pending·0 cites
- 2239US2020085776A1Methods of Reducing C-Reactive Protein and/or Treating Cardiovascular DiseaseCARDAX INC·Filed 2019·Application pending·0 cites
- 2338US2008221377A1Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediatesLOCKWOOD SAMUEL F·Filed 2007·Application pending·0 cites
- 2437US2005049248A1Carotenoid ether analogs or derivatives for controlling C-reactive protein levelsFiled 2004·Application pending·0 cites
- 2537US2005009788A1Carotenoid ester analogs or derivatives for controlling connexin 43 expressionFiled 2004·Application pending·0 cites
- 2635US2006058269A1Carotenoid analogs or derivatives for the inhibition and amelioration of inflammationLOCKWOOD SAMUEL F·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henry Jackson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →